openPR Logo
Press release

Computed Tomography to Drive The Orally Disintegrating Tablet Market

02-22-2022 10:39 AM CET | Health & Medicine

Press release from: Persistence Market Research

Computed Tomography to Drive The Orally Disintegrating Tablet

The Orally Disintegrating Tablet Market is expected to climb up the ladder of persistence in the next decade. With various healthcare apps on the anvil, there are also mindfulness apps being tabled. They fall in the category of "Wellness apps". With the world wishing for the post-Covid era to function smoothly, these wellness apps are expected to take the healthcare vertical by storm further.

Improvements in drug delivery mechanism offering quicker onset of action with superior bioavailability per dose have transformed characteristics of orally administered drugs with the development of orally disintegrating tablets (ODTs). The global orally disintegrating tablets market was valued at nearly US$ 12 Bn in 2018 and will exhibit a solid CAGR during the forecast period (2019 - 2029).

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/14572

There has been growing preference among consumers and patients for orally disintegrating tablets attributed to increasing applications in treatment of diseases related to central nervous system (CNS), gastrointestinal (GI), cardiovascular disorders, and allergy. Bayer's acquisition of Merck's consumer care unit was aimed at gaining shares in ODTs. Claritin, an ODT received through this acquisition, was the largest revenue generating drug for allergy in the U.S. that year.

Company Profiles:

Teva Pharmaceutical Industries Ltd.
Novartis AG
AstraZeneca
Mylan N.V.
Pfizer Inc.
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Bausch Health
GlaxoSmithKline plc.
Sun Pharmaceutical Industries Ltd.
Bayer AG
Eli Lily and Company
Dr. Reddy's Laboratories Ltd.
Takeda Pharmaceutical Company Limited

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/14572

Key Takeaways - Orally Disintegrating Tablets Market Study

CNS diseases remain the primary area of application for orally disintegrating tablets. Researchers and healthcare providers are increasingly focusing on medical conditions such as encephalitis, autism, Alzheimer's disease, schizophrenia, depressive disorders and others to increase the application of orally disintegrating tablets.
Formulation process of orally disintegrating tablets is usually patented by manufacturers depending on the technology employed during the production such as lyophilization, freeze drying, and floss formation. Many technologies such as ZYDIS®, LYOC® and QUICKSOLV® are dependent on freeze drying method.
Easy disintegration of orally disintegrating tablets in saliva within a few seconds and accuracy of dose as compared to liquid forms and chewable tablet are expected to increase the adoption of ODTs in diseases such as ulcers of throat.

Attributed to consumers facing swallowing problems, bitter taste of drugs, and patient incompliance, manufacturers are focusing to improve drug formulations. This would help them gain an edge in terms of innovation, further favoring the growth of orally disintegrating tablets market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/14572

Key Manufacturers Exploring New Business Models

The global orally disintegrating tablets market is fragmented with low entry barriers inspiring generic manufacturers to tap market opportunities in the form of ANDA, arising from the expiry of patent regime of approved drugs. For instance, Mylan N.V. launched Lansoprazole DR ODT, a generic version of Takeda's Prevacid® SoluTab DR ODT. The entry of The Himalaya Drug Company LTD. and Banyan Botanicals with new herbal ODT product offerings in next few years is expected to increase product lines and extension in ODTs market.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/orally-disintegrating-tablet-market.asp

Report Inclusions

Persistence Market Research offers a unique perspective and actionable insights on the Orally Disintegrating Tablets landscape in its new study, presenting historical demand assessment from 2014 - 2018 and projections from 2019 - 2029 on the basis of drug class (anti-psychotics, anti-epileptics, CNS stimulants, anxiolytics, anti-Parkinsonian drugs, anti-hypertensives, NSAIDS, anti-allergy drugs, proton pump inhibitors), disease indication (CNS diseases, GI diseases, allergy, CVS disorders), distribution channel (hospital pharmacies, retail pharmacies, drug stores, online pharmacies), and five key regions.

Related Reports:

Allergy Shots Market - https://www.persistencemarketresearch.com/market-research/allergy-shots-market.asp

Uveitis Treatment Market - https://www.persistencemarketresearch.com/market-research/uveitis-treatment-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Computed Tomography to Drive The Orally Disintegrating Tablet Market here

News-ID: 2559735 • Views:

More Releases from Persistence Market Research

Broadcast Scheduling Software Market on Pace to Reach US$ 5.8 Bn by 2032 - Persistence Market Research
Broadcast Scheduling Software Market on Pace to Reach US$ 5.8 Bn by 2032 - Persi …
The global broadcast scheduling software market has seen significant growth in recent years, and it is poised to continue this upward trajectory. This specialized software allows broadcasters to manage, plan, and organize content distribution across various platforms, including television, radio, and digital streaming services. With the increasing demand for precise content management and the rising popularity of on-demand streaming platforms, the role of broadcast scheduling software has become more vital
Liver Cirrhosis Treatment Market Expected to Reach USD 30.7 Billion by 2031 | Persistence Market Research
Liver Cirrhosis Treatment Market Expected to Reach USD 30.7 Billion by 2031 | Pe …
Overview of the Liver Cirrhosis Treatment Market The liver cirrhosis treatment market is poised for substantial growth, driven by the rising prevalence of liver diseases and advances in medical research. Liver cirrhosis, a chronic liver condition characterized by scarring and impaired liver function, remains a global healthcare challenge. The market, valued at approximately US$18.5 billion in 2024, is expected to grow significantly, with a forecasted value of US$30.7 billion by 2031,
Ice Merchandiser Market Estimated to Reach US$ 309.7 Mn by 2031 Amid Growing Cold Storage Needs in Foodservice
Ice Merchandiser Market Estimated to Reach US$ 309.7 Mn by 2031 Amid Growing Col …
The global ice merchandiser market is witnessing steady growth, driven by increasing demand for convenience, innovations in refrigeration technology, and expanding food and beverage retail networks. According to market estimates, the industry is projected to reach US$ 264.1 million in 2024 and grow at a CAGR of 2.3% during the forecast period, attaining a value of US$ 309.7 million by 2031. Get a Sample PDF Brochure of the Report (Use Corporate
Agricultural Mapping Services Market Poised for Remarkable Growth, Projected to Reach US$8.7 Billion by 2031 - Insights from Persistence Market Research
Agricultural Mapping Services Market Poised for Remarkable Growth, Projected to …
Overview of the Agricultural Mapping Services Market The global agricultural mapping services market is projected to grow at a CAGR of 5.1% from 2024 to 2031, expanding from an estimated value of US$6.2 billion in 2024 to US$8.7 billion by the end of 2031. This growth is driven by the increasing adoption of precision agriculture technologies, the rising demand for sustainable farming practices, and advancements in geospatial analytics. Get a Sample PDF

All 5 Releases


More Releases for ODT

Orally Disintegrating Tablet (ODT) Market Share 2021 Growth Challenges, Opportun …
The global orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). According to the US Food and Drug Administration (FDA), ODT’s are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the
Orally Dissolving Tablets (ODT) Excipient Market global outlook and forecast 202 …
The Global Orally Dissolving Tablets (ODT) Excipient Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Orally Dissolving Tablets (ODT) Excipient makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and
Investigation announced for Long-Term Investors in shares of Odonate Therapeutic …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Odonate Therapeutics, Inc.. Investors who are current long term investors in Odonate Therapeutics, Inc. (NASDAQ: ODT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ODT stocks follows a lawsuit filed against Odonate
Deadline on Nov. 16th coming up in Lawsuit for Investors in Odonate Therapeutics …
The Shareholders Foundation announced that a deadline is coming up on November 16, 2020 in the lawsuit filed for certain investors of Odonate Therapeutics, Inc. (NASDAQ: ODT) over alleged securities laws violations by Odonate Therapeutics, Inc. Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and there are strict and short deadlines running. Deadline: November 16, 2020. NASDAQ: ODT stockholders should contact the Shareholders Foundation at
Lawsuit filed for Investors in shares of Odonate Therapeutics, Inc. (NASDAQ: ODT …
An investor, who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT), filed a lawsuit over alleged Securities Laws violations by Odonate Therapeutics, Inc. Investors who purchased shares of Odonate Therapeutics, Inc. (NASDAQ: ODT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 16, 2020. NASDAQ: ODT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Diego, CA based Odonate Therapeutics,
Trending: Orally Disintegrating Tablet (ODT) Market By End-User Segments Forecas …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Orally Disintegrating Tablet (ODT) Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Orally Disintegrating Tablet (ODT) market is relied upon to develop generously and flourish